Abbott Laboratories (ABT)
107.25
-2.04
(-1.87%)
USD |
NYSE |
Nov 12, 16:00
107.24
-0.01
(-0.01%)
Pre-Market: 20:00
Abbott Laboratories Free Cash Flow (Quarterly) : 1.224B for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.224B |
| June 30, 2026 | 1.991B |
| March 31, 2026 | 916.00M |
| December 31, 2025 | 2.626B |
| September 30, 2025 | 2.291B |
| June 30, 2025 | 1.545B |
| March 31, 2025 | 933.00M |
| December 31, 2024 | 2.148B |
| September 30, 2024 | 2.149B |
| June 30, 2024 | 1.427B |
| March 31, 2024 | 627.00M |
| December 31, 2023 | 2.283B |
| September 30, 2023 | 1.317B |
| June 30, 2023 | 696.00M |
| March 31, 2023 | 763.00M |
| December 31, 2022 | 1.716B |
| September 30, 2022 | 2.313B |
| June 30, 2022 | 2.031B |
| March 31, 2022 | 1.744B |
| December 31, 2021 | 2.453B |
| September 30, 2021 | 2.24B |
| June 30, 2021 | 1.715B |
| March 31, 2021 | 2.24B |
| December 31, 2020 | 3.119B |
| September 30, 2020 | 1.57B |
| Date | Value |
|---|---|
| June 30, 2020 | 680.00M |
| March 31, 2020 | 355.00M |
| December 31, 2019 | 1.982B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 592.00M |
| March 31, 2019 | 377.00M |
| December 31, 2018 | 1.298B |
| September 30, 2018 | 1.829B |
| June 30, 2018 | 946.00M |
| March 31, 2018 | 833.00M |
| December 31, 2017 | 1.295B |
| September 30, 2017 | 1.742B |
| June 30, 2017 | 1.096B |
| March 31, 2017 | 302.00M |
| December 31, 2016 | 851.00M |
| September 30, 2016 | 905.00M |
| June 30, 2016 | 662.00M |
| March 31, 2016 | -336.00M |
| December 31, 2015 | 580.00M |
| September 30, 2015 | 784.00M |
| June 30, 2015 | 725.00M |
| March 31, 2015 | -233.00M |
| December 31, 2014 | 951.00M |
| September 30, 2014 | 924.00M |
| June 30, 2014 | 642.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 1.162B |
| Boston Scientific Corp. | 868.00M |
| DexCom, Inc. | 272.70M |
| Globus Medical, Inc. | 224.84M |
| Intuitive Surgical, Inc. | 1.111B |